Failure to pay annual charges - regulatory actions

If a sponsor has failed to pay the annual charge for therapeutic goods within 28 days (20 working days for medical devices) after it becomes payable, the Secretary can cancel the entry of therapeutic goods in the Australian Register of Therapeutic Goods (ARTG).

The cancellation provisions relating to failure to pay annual charges in the Therapeutic Goods Act 1989 are:

  • cancellation of listed or registered therapeutic goods: section 30(2)(f)
  • cancellation of biologicals: section 32GA(1)(g)
  • cancellation of medical devices: section 41GL(f).

The records below include information on the cancellation decisions and any subsequent decision to revoke such cancellations. To find out whether a product is currently authorised for supply in Australia, check the ARTG.

Enter a product name or an ARTG number.

Cancellations

Displaying 71 - 80 of 2259

Azpa Pharmaceuticals Pty Ltd

Product: Testofen Female Formula

ARTG number: 187768

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: Testofen Male Formula

ARTG number: 187230

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: OmegCaps 18:12 1500 mg

ARTG number: 186639

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Azpa Pharmaceuticals Pty Ltd

Product: OmegCaps 18:12

ARTG number: 170322

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: Eaze Fat Reducer-Assists in Weight loss

ARTG number: 216125

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: Gastroeaze

ARTG number: 197302

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: pm Cyrin

ARTG number: 182557

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: Osteoartheaze Joint Bone and Vein Support

ARTG number: 150838

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: Eaze Fat Reducer - Assists in weight loss

ARTG number: 150835

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

N'Kapharma Pharmaceutical Export Pt

Product: Osteoartheaze Plus Pain Inhibitors

ARTG number: 150832

Type of decision: Cancelled under 41GL(f) of the Act

Date of effect: 16 Jun 2017

Pages